Cargando…

Renoprotective activity of anethole- rich fraction from aromatic herbs on junk food induced diabetic nephropathy in rats

PURPOSE: This study was carried out to study the effect of anethole rich fraction on the Diabetic Nephropathy (DN) rats, and explore the mechanisms. METHODS: Male wistar rats were grouped into 4 (n = 6 per group): Control, junk food fed DN induced rats, low dose and high dose groups. DN was induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vellapandian, Chitra, R, Rini, Ramachandram, Dinesh Sangarran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672211/ https://www.ncbi.nlm.nih.gov/pubmed/36404830 http://dx.doi.org/10.1007/s40200-022-01101-4

Ejemplares similares

Photocatalytic Isomerization of (E)-Anethole to (Z)-Anethole
por: Korff, Marvin, et al.
Publicado: (2022)

Junk Science, Junk Journals, and Junk Publishing Management: Risk to Science’s Credibility
por: Teixeira da Silva, Jaime A.
Publicado: (2022)

Junk Food Exposure Disrupts Selection of Food-Seeking Actions in Rats
por: Kosheleff, Alisa R., et al.
Publicado: (2018)

Junk Food Marketing on Instagram: Content Analysis
por: Vassallo, Amy Jo, et al.
Publicado: (2018)

Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
por: Zhang, Lei, et al.
Publicado: (2020)

EFFECTS OF ANETHOLE ON SEMINAL VESICLE OF ALBINO RATS
por: Farook, T., et al.
Publicado: (1991)

Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy
por: El-Kady, Mohamed M., et al.
Publicado: (2021)

Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022)

Insulin therapy in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Statin use in patients with diabetes amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Use of sulforaphane in COVID-19: Clinical trials are needed
por: Kow, Chia Siang, et al.
Publicado: (2022)

Future of antivirals in COVID-19: The case of favipiravir
por: Kow, Chia Siang, et al.
Publicado: (2022)

Can COVID-19 vaccines improve cardiovascular outcomes?
por: Kow, Chia Siang, et al.
Publicado: (2022)

Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant
por: Kow, Chia Siang, et al.
Publicado: (2021)

Metformin in COVID-19: clinical trials are needed to prove its benefits
por: Kow, Chia Siang, et al.
Publicado: (2022)

The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2022)

Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2022)

The use of corticosteroids in patients with COVID-19 vaccine–related cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2022)

Hyperbaric oxygen therapy to reverse post-COVID cognitive impairment
por: Kow, Chia Siang, et al.
Publicado: (2022)

Probiotics for the Prevention of COVID-19 Sequelae
por: KOW, CHIA SIANG, et al.
Publicado: (2022)

Metformin therapy in COVID-19: inhibition of NETosis
por: Kow, Chia Siang, et al.
Publicado: (2022)

Aspirin Therapy in COVID-19: Prevention of NETosis
por: Kow, Chia Siang, et al.
Publicado: (2023)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Statin Therapy in COVID-19: Inhibition of NETosis
por: Kow, Chia Siang, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Hypertension and severe COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Coenzyme Q10 therapy in patients with post COVID-19 condition
por: Kow, Chia Siang, et al.
Publicado: (2023)

Should COVID-19 be considered cardiovascular disease risk equivalent?
por: Kow, Chia Siang, et al.
Publicado: (2023)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2023)

Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’
por: Kow, Chia Siang, et al.
Publicado: (2023)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’
por: Kow, Chia Siang, et al.
Publicado: (2023)

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2023)

How to make the best of NLRP3 inhibitors in patients with COVID-19?
por: Kow, Chia Siang, et al.
Publicado: (2023)

Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment
por: Kow, Chia Siang, et al.
Publicado: (2023)

RAAS inhibitors in COVID-19: not all are created equal!
por: Kow, Chia Siang, et al.
Publicado: (2023)

Favipiravir and hyperuricemia in patients with COVID-19—suggestions for future studies
por: Kow, Chia Siang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ct62a8s23d5rfh3n7su1m9q98